![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/48 | |
A61K 31/519 | |||
A61P 35/00 | |||
C07D 487/04 | |||
A61P 35/02 |
(11) | Number of the document | 3073999 |
(13) | Kind of document | T |
(96) | European patent application number | 14866302.4 |
Date of filing the European patent application | 2014-11-26 | |
(97) | Date of publication of the European application | 2016-10-05 |
(45) | Date of publication and mention of the grant of the patent | 2018-05-30 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/067586 |
Date | 2014-11-26 |
(87) | Number | WO 2015/081180 |
Date | 2015-06-04 |
(30) | Number | Date | Country code |
201310616065 | 2013-11-27 | CN | |
201410542609 | 2014-10-14 | CN |
(72) |
CHEN, Minhua, US
ZHANG, Yanfeng, CN
YANG, Chaohui, CN
ZHANG, Xiaoyu, CN
LU, Fei, CN
GE, Heng, CN
WANG, Peng, US
LI, Pixu, CN
|
(73) |
Crystal Pharmatech Co., Ltd.,
B4-101 Biobay 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215123,
CN
Suzhou Pengxu Pharmatech Co., Ltd., 3rd Floor, Building E 2358 ChangAn Road Wujiang, Suzhou, Jiangsu 215200, CN |
(54) | CRYSTALLINE FORM I OF IBRUTINIB |
CRYSTALLINE FORM I OF IBRUTINIB |